Tudor Investment Corp
TNGX icon

Tudor Investment Corp’s Tango Therapeutics TNGX Stock Holding History

Tudor Investment Corp’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-68,251
Closed -$605K – 4278
2025
Q4 		$605K Buy
68,251
+14,679
+27% +$126K ﹤0.01% 2605
2025
Q3 		$450K Buy
+53,572
New +$363K ﹤0.01% 2755
2025
Q2 		– Sell
-34,060
Closed -$46.7K – 3751
2025
Q1 		$46.7K Sell
34,060
-26,554
-44% -$65.2K ﹤0.01% 2958
2024
Q4 		$187K Sell
60,614
-2,682
-4% -$12.5K ﹤0.01% 2857
2024
Q3 		$487K Buy
+63,296
New +$604K ﹤0.01% 2052
2024
Q2 		– Sell
-50,894
Closed -$404K – 2798
2024
Q1 		$404K Sell
50,894
-1,211
-2% -$13K ﹤0.01% 1741
2023
Q4 		$516K Buy
+52,105
New +$452K ﹤0.01% 1779

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return

Tudor Investment Corp's TNGX Position: Q1 2026 in Review

Tudor Investment Corp sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 68,251 shares — an estimated $605K sold.

Tudor Investment Corp first reported a position in TNGX in Q4 2023 and held it in 7 quarters. The position peaked at $605K in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Tudor Investment Corp reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 68,251 Tango Therapeutics shares in Q1 2026, an estimated $605K.
  • Tudor Investment Corp first reported a position in Tango Therapeutics in Q4 2023 and held it in 7 quarters.
  • Tudor Investment Corp's Tango Therapeutics position peaked at $605K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.